Physician profile
Megan E Moore
NPI 1316445901
$432.02
in general payments reported to CMS, 2019-2025
12 companies · $88.46 in 2025
The $88.46 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $62.12 · 2022: $84.65 · 2023: $64.53 · 2024: $132 · 2025: $88.46.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $285.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $285.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cranial Technologies, INC | $121.79 | 2022-2025 | Doc Band |
| Sanofi Pasteur INC. | $70.55 | 2022-2024 | |
| Daiichi Sankyo INC. | $55.99 | 2024-2025 | Enhertu |
| Kaleo, INC. | $26.86 | 2021 | |
| Eisai INC. | $23.78 | 2024 | |
| Verrica Pharmaceuticals INC. | $23.60 | 2024 | Ycanth |
| Merck Sharp & Dohme LLC | $23.17 | 2021 | |
| Rhythm Pharmaceuticals, INC. | $22.91 | 2022 | |
| Collegium Pharmaceutical, INC. | $19.19 | 2025 | Jornay Pm |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $17.58 | 2022 | |
| Aimmune Therapeutics, INC. | $14.51 | 2023 | |
| Genentech USA, INC. | $12.09 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Megan Moore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.